ALNY — Alnylam Pharmaceuticals Inc
In 2026 Q2, 8 of the 140 tracked hedge funds reported a position in Alnylam Pharmaceuticals Inc (ALNY), worth $171.05M combined. Over the quarter 6 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $145.32M | 0.41% | +87.3% |
| VanEck | $17.66M | 0.01% | +8.4% |
| Quadrature | $6.82M | 0.06% | -73.4% |
| Polymer | $425.96K | 0.06% | NEW |
| Caxton Associates | $286.58K | 0.00% | NEW |
| Emerald | $276.95K | 0.00% | -43.3% |
| Chapin Davis | $255.88K | 0.05% | +0.7% |
| Barnes Dennig | $602 | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.